Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma

Clinical trial NCT07144384 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07144384
Sponsor: Ohio State University Comprehensive Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Skin Basal Cell Carcinoma Skin Nodular Basal Cell Carcinoma Skin Squamous Cell Carcinoma

Start date: 2025-10-16
Primary completion: 2026-04-03
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.